-
SARS-CoV-2 NSP15 Inhibitors: Thymopentin and Oleuropein
2026-09-10
A 2021 structure-based screening study identified thymopentin and oleuropein as the most favorable predicted binders of SARS-CoV-2 NSP15, an endoribonuclease involved in viral immune evasion. Molecular dynamics simulations supported the persistence of both complexes, but biochemical, cellular, and in vivo validation remain necessary before these compounds can be considered antiviral inhibitors.
-
Risedronate Sodium: Applied Research Workflows
2026-09-10
Risedronate Sodium combines FPPS pathway activity with flexible delivery options for bone, pulmonary, and formulation research. This guide translates published nanotransferosome–microneedle results into practical cell, ex vivo, and in vivo workflows with troubleshooting checkpoints.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO)
2026-09-09
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during cell or tissue lysis, with compatibility advantages for workflows that require divalent cations. Use it at least 200-fold diluted, but do not treat it as a metal chelator or assume compatibility with DMSO-sensitive assays without testing.
-
Alfuzosin Hydrochloride Assay Guide
2026-09-09
A scenario-based guide to using Alfuzosin Hydrochloride (SKU A5173) in cell viability, proliferation, and cytotoxicity workflows. It addresses solvent compatibility, endpoint controls, data interpretation, and practical criteria for selecting a reliable research-grade source.
-
Streptavidin-FITC for Glycan–Microbe Assays
2026-09-08
Explore how Streptavidin-FITC converts biotinylated adhesion and glycan measurements into interpretable fluorescence. This guide connects the ST3GAL1–Fusobacterium nucleatum model with practical assay design, controls, and workflow decisions.
-
E-64 Workflows for Cysteine Protease Assays
2026-09-08
E-64 combines irreversible active-site chemistry with nanomolar potency, making it useful for enzyme profiling, cathepsin-dependent cell-death studies, and mechanistic cancer research. This guide connects assay design, lysosomal membrane permeabilization workflows, troubleshooting, and practical handling decisions.
-
HSP90–METTL3 Control of MYC m6A in Colorectal Cancer
2026-09-07
This study identifies METTL3 as an HSP90 client protein and defines an HSP90–METTL3–MYC regulatory axis in colorectal cancer. By linking HSP90 inhibition to CHIP-mediated METTL3 degradation, reduced MYC mRNA m6A modification, and impaired malignant phenotypes, the work provides a mechanistic framework for targeting RNA modification through chaperone biology.
-
NLRP10, Keratinocyte Survival, and Skin Barrier
2026-09-07
The reference study identifies NLRP10 as a regulator of epidermal homeostasis that links keratinocyte survival with p63-dependent differentiation and barrier formation. Using human atopic dermatitis samples and an air-lift human skin-equivalent model, the authors connect reduced NLRP10 activity to caspase-8 signaling, impaired epidermal maturation, and defective barrier function.
-
Fasudil (HA-1077) HCl for ROCK Assays
2026-09-05
Fasudil (HA-1077) HCl provides a practical perturbation tool for separating ROCK-dependent cytoskeletal effects from Hippo-pathway responses in lens epithelial and cancer-cell experiments. This guide translates cataract-model findings into dose-finding, migration, proliferation, apoptosis, and pathway-validation workflows without treating fasudil as an established cataract therapy.
-
Leupeptin hemisulfate salt: assay reliability
2026-09-04
Learn how Leupeptin, Microbial (Leupeptin hemisulfate), SKU A2570, can help control proteolysis during viability, proliferation, cytotoxicity, and protein-degradation workflows. This scenario-based guide covers enzyme specificity, solution handling, live-cell limitations, orthogonal validation, and practical vendor-selection criteria.
-
BIBR 1532: Telomerase Inhibitor Workflows
2026-09-04
BIBR 1532 enables mechanism-focused studies that separate rapid telomerase inhibition from slower telomere attrition and downstream apoptosis. This guide translates its hTERT-directed activity into practical assay workflows, combination experiments, and troubleshooting strategies for oncology research.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-09-03
The 2024 Development study establishes a mechanistic link between SMPD4-dependent ceramide production, primary cilium integrity, and mammalian brain development. By combining a mouse model with SMPD4-deficient human iPSC-derived neural cells and ceramide rescue, the authors connect sphingolipid metabolism to neural progenitor survival and Purkinje cell development.
-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-09-03
The reference study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By combining pharmacological inhibition, mass cytometry, mouse injury models, network modeling, and transcriptomic datasets, it links impaired WNT5a signaling to fatty degeneration and proposes pathway restoration as a strategy for improving muscle regeneration.
-
AG-126 in ERK Signaling and Neurobehavioral Assays
2026-09-02
AG-126 provides a reversible chemical way to test ERK1/2 involvement alongside cell-type-specific neurobiology and inflammatory stimulation. This article translates findings from a Neuroligin 1–D2-MSN study into practical phosphorylation, cytokine, and model-comparison workflows while emphasizing controls and assay limitations.
-
Protease and Phosphatase Inhibitor Cocktail Guide
2026-09-02
Learn how a Protease and Phosphatase Inhibitor Cocktail preserves protein abundance and phosphorylation states in epithelial signaling studies. This guide translates PTGER4–HDAC biology into practical extraction, assay-design, and EDTA-free workflow decisions.